David Alexandre C Gros is Chief Executive Officer of Eledon Pharmaceuticals, Inc.. Currently has a direct ownership of 9,000 shares of ELDN, which is worth approximately $37,260. The most recent transaction as insider was on Dec 20, 2021, when has been sold 2,000 shares (Common Stock) at a price of $4.48 per share, resulting in proceeds of $8,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9K
0% 3M change
0% 12M change
Total Value Held $37,260

David-Alexandre C Gros Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 20 2021
BUY
Open market or private purchase
$8,960 $4.48 p/Share
2,000 Added 18.18%
9,000 Common Stock
Aug 17 2021
BUY
Open market or private purchase
$24,840 $6.21 p/Share
4,000 Added 36.36%
7,000 Common Stock
Jun 09 2021
BUY
Open market or private purchase
$24,030 $8.01 p/Share
3,000 Added 50.0%
3,000 Common Stock
DCG

David Alexandre C Gros

Chief Executive Officer
Irvine, CA

Track Institutional and Insider Activities on ELDN

Follow Eledon Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELDN shares.

Notify only if

Insider Trading

Get notified when an Eledon Pharmaceuticals, Inc. insider buys or sells ELDN shares.

Notify only if

News

Receive news related to Eledon Pharmaceuticals, Inc.

Track Activities on ELDN